In the last trading session, 8.46 million Hepion Pharmaceuticals Inc (NASDAQ:HEPA) shares changed hands as the company’s beta touched 1.65. With the company’s per share price at $0.16 changed hands at -$0.02 or -9.64% during last session, the market valuation stood at $1.73M. HEPA’s last price was a discount, traded about -2081.25% off its 52-week high of $3.49. The share price had its 52-week low at $0.12, which suggests the last value was 25.0% up since then. When we look at Hepion Pharmaceuticals Inc’s average trading volume, we note the 10-day average is 101.23 million shares, with the 3-month average coming to 16.65 million.
Analysts gave the Hepion Pharmaceuticals Inc (HEPA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 3.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended HEPA as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Hepion Pharmaceuticals Inc’s EPS for the current quarter is expected to be 0.
Hepion Pharmaceuticals Inc (NASDAQ:HEPA) trade information
Instantly HEPA was in red as seen at the end of in last trading. With action -1.70%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -65.50%, with the 5-day performance at -1.70% in the red. However, in the 30-day time frame, Hepion Pharmaceuticals Inc (NASDAQ:HEPA) is -65.50% down. Looking at the short shares, we see there were 65726.0 shares sold at short interest cover period of 0.92 days.
The consensus price target for the stock as assigned by Wall Street analysts is 70, meaning bulls need an upside of 99.77% from its current market value. According to analyst projections, HEPA’s forecast low is 70 with 70 as the target high. To hit the forecast high, the stock’s price needs a -43650.0% plunge from its current level, while the stock would need to soar -43650.0% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 63.67%.
HEPA Dividends
Hepion Pharmaceuticals Inc is expected to release its next quarterly earnings report in March.
Hepion Pharmaceuticals Inc (NASDAQ:HEPA)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.08% of Hepion Pharmaceuticals Inc shares while 7.85% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 7.85%.
